Compare PTCT & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | BBUC |
|---|---|---|
| Founded | 1998 | 2022 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.9B |
| IPO Year | 2006 | 2015 |
| Metric | PTCT | BBUC |
|---|---|---|
| Price | $71.41 | $27.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $80.65 | $41.00 |
| AVG Volume (30 Days) | ★ 794.0K | 266.5K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.70 | N/A |
| P/E Ratio | $79.77 | ★ N/A |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $57.08 | $26.93 |
| 52 Week High | $90.87 | $38.25 |
| Indicator | PTCT | BBUC |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 35.50 |
| Support Level | $67.57 | N/A |
| Resistance Level | $73.86 | $32.12 |
| Average True Range (ATR) | 2.00 | 0.68 |
| MACD | 0.17 | -0.07 |
| Stochastic Oscillator | 54.41 | 13.21 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Brookfield Business Corp is the operator of vital industrial and business services operations. The company focuses on acquiring market businesses for value, execute its operational improvement plans to increase cash flows and recycle capital to compound long-term growth. Geographically, it derives maximum revenue from the United States, and the rest from Europe, Brazil, Australia, Canada, and others. It operates in four segments within particular sectors namely: business services, infrastructure services, industrials, and corporate. The company derives maximum revenue from Industrials segment engaged in energy storage operations, engineered components manufacturing operations, water and wastewater operations, electric heat tracing systems manufacturer, and other industrials operations.